Both drugs share the same key ingredient, tirzepatide
In addition, this study focused mainly on ovarian GCs and failed to comprehensively assess the effects of PLB on other relevant cell types, such as follicular epithelial cells and immune cells
Mounjaro (tirzepatide): A GIP and GLP-1 receptor agonist, offering a dual-action approach to weight loss and blood sugar control, approved for type 2 diabetes and increasingly for weight management
Effects of weight loss on ventricular systolic and diastolic functions and left ventricular mass assessed by tissue doppler imaging in obese geriatric women: preliminary report
We therefore examined the levels of free fatty acids in the three sterile mutants and WT worms using LC-MS
Surg Endosc 35(8):46444652 Palanca A, Ampudia-Blasco FJ, Caldern JM et al (2023) Real-world evaluation of GLP-1 receptor agonist therapy persistence, adherence and therapeutic inertia among obese adults with type 2 diabetes